Treatment with injection dopamine (a drug acting on kidney and heart) to prevent kidney failure in patients with long term kidney disease undergoing for heart bypass operation

Therapeutic effect of renal dose of dopamine in acute on chronic renal failure: An interventional study in off pump CABG patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027373

Enrollment

100

Registered

2020-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: DOPAMINE INFUSION: DOPAMINE INFUSION WILL BE GIVEN TO PATIENTS WITH ACUTE ON CHRONIC RENAL FAILUE, DOSE: 3 TO 5 MICROGRAMS/KG/MINUTE, FREQUENCY: CONTINEOUS INFUSSION, ROUTE: INTRAVENOU

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WHO DEVELOP ACUTE ON CHRONIC RENAL FAILURE IN THE POST OPERATIVE PERIOD OF OFF PUMP CABG

Exclusion criteria

Exclusion criteria: 1.PATIENT WHO REFUSED CONSENT 2.DIALYSIS DEPENDENT CHRONIC RENAL FAILURE

Design outcomes

Secondary

Measure	Time frame
MORBIDITY OUTCOMETimepoint: DURING 10 DAYS AFTER CABG	—

Primary

Measure	Time frame
1.AVOIDENCE OF HEMODIALYSIS 2.MORTALITY BENEFITTimepoint: 1.AVOIDENCE OF HEMODIALYSIS 2.MORTALITY BENEFIT DURING 10 DAYS AFTER CABG	—

Countries

India

Contacts

Public ContactThiruvenkadam Selvaraj

KARPAGAM FACULTY OF MEDICAL SCIENCES & RESEARCH

mail2drthiru@yahoo.co.in8883980999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026